Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 52.26 M63.94 M — Research & development —— — Operating income -120.79 M-111.4 M — Non-Operating Income, Total -39.91 M-29.29 M — Interest expense, net of interest capitalized 314 K1.48 M — Non-Operating Income, excl. Interest Expenses -32.58 M-45.18 M — Unusual income/expense -7.64 M14.42 M — Pretax income -160.7 M-140.69 M — Equity in earnings —— — Taxes -1.19 M135 K — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -159.51 M-140.82 M — Discontinued operations —— — Net income -159.51 M-140.82 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 159.51 M140.82 M — Basic earnings per share (Basic EPS) -6.6723.5 — Diluted earnings per share (Diluted EPS) -6.6723.5 — Average basic shares outstanding 2.59 M12.08 M — Diluted shares outstanding 2.59 M12.08 M — EBITDA -118.69 M-109.4 M — EBIT -120.79 M-111.4 M — Cost of revenue —— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 2.1 M2 M —